<style face="normal" font="default" size="100%">POS-254 CLINICAL AND SAFETY OUTCOMES WITH APIXABAN VERSUS WARFARIN BY EGFR IN ADULTS WITH ATRIAL FIBRILLATION</style>

Drupal-Bibcite